 Connection
Jason Glanz to Pneumococcal Vaccines
This is a "connection" page, showing publications Jason Glanz has written about Pneumococcal Vaccines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.756 |
|
|
|
-
Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 2011 Jan 29; 29(5):994-9.
Score: 0.305
-
Albers AN, Fox ER, Michels SY, Daley MF, Glanz JM, Newcomer SR. Late initiation of pneumococcal and Haemophilus influenzae type b vaccinations. Vaccine. 2025 Aug 30; 62:127611.
Score: 0.211
-
Wang SV, Stefanini K, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub E, Kulldorff M. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
Score: 0.150
-
Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, Yih K, Baxter R, Glanz JM, Donahue J, Naleway A, Nordin J, Jacobsen SJ. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013 May 24; 31(22):2578-83.
Score: 0.090
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|